Cargando…
Impact of treatment heterogeneity on drug resistance and supply chain costs()
The efficacy of scarce drugs for many infectious diseases is threatened by the emergence and spread of resistance. Multiple studies show that available drugs should be used in a socially optimal way to contain drug resistance. This paper studies the tradeoff between risk of drug resistance and opera...
Autores principales: | Spiliotopoulou, Eirini, Boni, Maciej F., Yadav, Prashant |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Pergamon Press
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4375612/ https://www.ncbi.nlm.nih.gov/pubmed/25843982 http://dx.doi.org/10.1016/j.seps.2013.04.001 |
Ejemplares similares
-
Costing the supply chain for delivery of ACT and RDTs in the public sector in Benin and Kenya
por: Shretta, Rima, et al.
Publicado: (2015) -
Investigating the Quality of Life for Cancer Patients and Estimating the Cost of Immunotherapy in Selected Cases
por: Fragkiadakis, Georgios F, et al.
Publicado: (2022) -
The public health sector supply chain costs in Tanzania
por: Ruhago, George M., et al.
Publicado: (2022) -
Supply Chain 4.0: the impact of supply chain digitalization and integration on firm performance
por: Liu, Kam Pui, et al.
Publicado: (2021) -
Reuse of shipping materials in the intravitreal bevacizumab supply chain: feasibility, cost, and environmental impact
por: Vo, Loi V., et al.
Publicado: (2023)